Skip to main content
Contact Us
Subscribe
E-Edition
85°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Champions Oncolog
(NQ:
CSBR
)
4.635
+0.226 (+5.13%)
Streaming Delayed Price
Updated: 2:16 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Champions Oncolog
< Previous
1
2
3
Next >
Champions Oncology Reports Quarterly Revenue of $13.1 Million
July 24, 2023
Via
ACCESSWIRE
Champions Oncology's Earnings: A Preview
July 21, 2023
Via
Benzinga
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 24, 2023
July 20, 2023
Via
ACCESSWIRE
Champions Oncology Announces the Formation of Corellia AI, a Wholly Owned Biotech that Leverages Unique AI-Enabled Workflows for Novel Therapeutic Development
April 17, 2023
Via
ACCESSWIRE
Champions Oncology Announces $5M Stock Repurchase Program
April 05, 2023
Via
ACCESSWIRE
Champions Oncology's Earnings: A Preview
March 14, 2023
Via
Benzinga
Champions Oncology's Return On Capital Employed Insights
December 30, 2022
Via
Benzinga
Champions Oncology Reports Quarterly Revenue of $12.9 Million
July 21, 2022
Via
ACCESSWIRE
$5M Bet On Pyxis Oncology? Check Out These 4 Penny Stocks Insiders Are Buying
March 22, 2023
The Dow Jones closed higher by more than 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Champions Oncology Reports Quarterly Revenue of $12.8 Million
March 15, 2023
Via
ACCESSWIRE
Earnings Scheduled For March 15, 2023
March 15, 2023
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.
Via
Benzinga
Champions Oncology to Announce Third Quarter Financial Results on Wednesday, March 15, 2023
March 13, 2023
Via
ACCESSWIRE
Analyzing Champions Oncology's Short Interest
December 15, 2022
Champions Oncology's (NASDAQ:CSBR) short percent of float has risen 6.9% since its last report. The company recently reported that it has 64 thousand shares sold short, which is 0.93% of all regular...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 15, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 14, 2022
Via
Benzinga
Champions Oncology Reports Record Quarterly Revenue of $14.3 Million
December 13, 2022
Via
ACCESSWIRE
Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 13, 2022
December 09, 2022
Via
ACCESSWIRE
Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday
September 16, 2022
Gainers
Via
Benzinga
Champions Oncology Reports Record Quarterly Revenue of $13.7 Million
September 08, 2022
Via
ACCESSWIRE
Earnings Scheduled For September 8, 2022
September 08, 2022
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report earnings for its second quarter. • Sono Group (NASDAQ:SEV) is estimated to report earnings for its second...
Via
Benzinga
Earnings Preview For Champions Oncology
September 07, 2022
Champions Oncology (NASDAQ:CSBR) is set to give its latest quarterly earnings report on Thursday, 2022-09-08. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Champions Oncology to Announce First Quarter Financial Results on Thursday, September 8, 2022
September 06, 2022
Via
ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $12.9 Million
July 21, 2022
Record Annual Revenue of $49.1 Million
From
Champions Oncology, Inc.
Via
AccessWire
A Preview Of Champions Oncology's Earnings
July 20, 2022
Champions Oncology (NASDAQ:CSBR) is set to give its latest quarterly earnings report on Thursday, 2022-07-21. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 21, 2022
July 14, 2022
HACKENSACK, NJ / ACCESSWIRE / July 14, 2022 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven...
From
Champions Oncology, Inc.
Via
AccessWire
Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics
May 31, 2022
HACKENSACK, NJ and TORONTO, ON / ACCESSWIRE / May 31, 2022 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative...
From
Champions Oncology, Inc.
Via
AccessWire
Earnings Scheduled For July 21, 2022
July 21, 2022
Companies Reporting Before The Bell • SAP (NYSE:SAP) is projected to report quarterly earnings at $1.15 per share on revenue of $7.56 billion.
Via
Benzinga
Champions Oncology Announces its Lumin Bioinformatics Platform Selected as a Finalist for the 'Best in Show' Competition at Bio-IT World Conference & Expo
May 03, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
Champions Oncology, Inc.
Via
AccessWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Here's How Much You Would Have Made Owning Champions Oncology Stock In The Last 5 Years
March 21, 2022
Champions Oncology (NASDAQ:CSBR) has outperformed the market over the past 5 years by 7.88% on an annualized basis. Buying $1,000 In CSBR: 5 years ago, an investor could have...
Via
Benzinga
Champions Oncology Earnings Perspective: Return On Capital Employed
March 16, 2022
According to Benzinga Pro, during Q3, Champions Oncology (NASDAQ:CSBR) earned $787.00 thousand, a 184.12% increase from the preceding quarter. Champions Oncology also posted a...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.